PER1 and lung adenocarcinoma: Compared with normal tissues, PER1 showed low expression levels in bladder cancer, breast cancer, colon cancer, kidney cancer, lung adenocarcinoma, lung squamous cell cancer, pancreatic cancer, gastric cancer, and urethral epithelial cancer tissues, while there was no control samples were available for OV (Figure 1B).